BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 35001247)

  • 1. MicroRNA expression is deregulated by aberrant methylation in B-cell acute lymphoblastic leukemia mouse model.
    Wang Y; Wang Y; Hui H; Fan X; Wang T; Xia W; Liu L
    Mol Biol Rep; 2022 Mar; 49(3):1731-1739. PubMed ID: 35001247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of miR-196b is not exclusively MLL-driven but is especially linked to activation of HOXA genes in pediatric acute lymphoblastic leukemia.
    Schotte D; Lange-Turenhout EA; Stumpel DJ; Stam RW; Buijs-Gladdines JG; Meijerink JP; Pieters R; Den Boer ML
    Haematologica; 2010 Oct; 95(10):1675-82. PubMed ID: 20494936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel miRNA genes deregulated by aberrant methylation in ovarian carcinoma are involved in metastasis.
    Loginov VI; Pronina IV; Burdennyy AM; Filippova EA; Kazubskaya TP; Kushlinsky DN; Utkin DO; Khodyrev DS; Kushlinskii NE; Dmitriev AA; Braga EA
    Gene; 2018 Jul; 662():28-36. PubMed ID: 29631007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Expression and Promoter CpG Island Methylation Status of miR-34b in Leukemia Cell Lines and Their Clinical Significance].
    Guo JX; Zhou YH; Guan RT; Pan JX; Zhang XY; Zhong JF
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Oct; 23(5):1235-9. PubMed ID: 26524015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low expression of miR-182 caused by DNA hypermethylation accelerates acute lymphocyte leukemia development by targeting PBX3 and BCL2: miR-182 promoter methylation is a predictive marker for hypomethylation agents + BCL2 inhibitor venetoclax.
    Li D; Yuan Y; Meng C; Lin Z; Zhao M; Shi L; Li M; Ye D; Cai Y; He X; Ye H; Zhou S; Zhou H; Gao S
    Clin Epigenetics; 2024 Mar; 16(1):48. PubMed ID: 38528641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methylation level of CpG islands in GGH gene promoter in pediatric acute leukemia.
    Li Y; Liu S; Wang H; Mai H; Yuan X; Li C; Chen X; Wen F
    PLoS One; 2017; 12(3):e0173472. PubMed ID: 28278270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methylation of the HOXA10 Promoter Directs miR-196b-5p-Dependent Cell Proliferation and Invasion of Gastric Cancer Cells.
    Shao L; Chen Z; Peng D; Soutto M; Zhu S; Bates A; Zhang S; El-Rifai W
    Mol Cancer Res; 2018 Apr; 16(4):696-706. PubMed ID: 29453320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA methylation contributes to deregulation of 12 cancer-associated microRNAs and breast cancer progression.
    Pronina IV; Loginov VI; Burdennyy AM; Fridman MV; Senchenko VN; Kazubskaya TP; Kushlinskii NE; Dmitriev AA; Braga EA
    Gene; 2017 Mar; 604():1-8. PubMed ID: 27998789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CpG island methylation status of miRNAs in esophageal squamous cell carcinoma.
    Chen X; Hu H; Guan X; Xiong G; Wang Y; Wang K; Li J; Xu X; Yang K; Bai Y
    Int J Cancer; 2012 Apr; 130(7):1607-13. PubMed ID: 21547903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigenetic silencing of miRNA-9 is correlated with promoter-proximal CpG island hypermethylation in gastric cancer in vitro and in vivo.
    Li Y; Xu Z; Li B; Zhang Z; Luo H; Wang Y; Lu Z; Wu X
    Int J Oncol; 2014 Dec; 45(6):2576-86. PubMed ID: 25270964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low expression of miR-196b enhances the expression of BCR-ABL1 and HOXA9 oncogenes in chronic myeloid leukemogenesis.
    Liu Y; Zheng W; Song Y; Ma W; Yin H
    PLoS One; 2013; 8(7):e68442. PubMed ID: 23894305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene silencing of MIR22 in acute lymphoblastic leukaemia involves histone modifications independent of promoter DNA methylation.
    Li X; Liu J; Zhou R; Huang S; Huang S; Chen XM
    Br J Haematol; 2010 Jan; 148(1):69-79. PubMed ID: 19807731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigenetic silencing of microRNA-34b/c and B-cell translocation gene 4 is associated with CpG island methylation in colorectal cancer.
    Toyota M; Suzuki H; Sasaki Y; Maruyama R; Imai K; Shinomura Y; Tokino T
    Cancer Res; 2008 Jun; 68(11):4123-32. PubMed ID: 18519671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of DNA methylation on the proliferation of leukemia cells regulated by miR-34b].
    Cao L; Wang N; Pan J; Gu G; Hu S; Zhao W; Chai Y
    Zhonghua Er Ke Za Zhi; 2014 Nov; 52(11):840-5. PubMed ID: 25582471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA expression profiling and DNA methylation signature for deregulated microRNA in cutaneous T-cell lymphoma.
    Sandoval J; Díaz-Lagares A; Salgado R; Servitje O; Climent F; Ortiz-Romero PL; Pérez-Ferriols A; Garcia-Muret MP; Estrach T; Garcia M; Nonell L; Esteller M; Pujol RM; Espinet B; Gallardo F
    J Invest Dermatol; 2015 Apr; 135(4):1128-1137. PubMed ID: 25405321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigenetic regulation of miR-196b expression in gastric cancer.
    Tsai KW; Hu LY; Wu CW; Li SC; Lai CH; Kao HW; Fang WL; Lin WC
    Genes Chromosomes Cancer; 2010 Nov; 49(11):969-80. PubMed ID: 20662076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetic silencing of miR-342-3p in B cell lymphoma and its impact on autophagy.
    Zhang MY; Calin GA; Yuen KS; Jin DY; Chim CS
    Clin Epigenetics; 2020 Oct; 12(1):150. PubMed ID: 33076962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of human gastric carcinoma-related methylation of 9 miR CpG islands and repression of their expressions in vitro and in vivo.
    Du Y; Liu Z; Gu L; Zhou J; Zhu BD; Ji J; Deng D
    BMC Cancer; 2012 Jun; 12():249. PubMed ID: 22703336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methylation-associated silencing of microRNA-34b in hepatocellular carcinoma cancer.
    Xie K; Liu J; Chen J; Dong J; Ma H; Liu Y; Hu Z
    Gene; 2014 Jun; 543(1):101-7. PubMed ID: 24704024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative analysis of epi-miRNA expression levels in local/locally advanced and metastatic prostate cancer patients.
    Gurbuz V; Kiliccioglu I; Dikmen AU; Bilen CY; Sozen S; Konac E
    Gene; 2020 Oct; 758():144963. PubMed ID: 32683077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.